[ad_1]
THE FIRST human trials of a ground-breaking drug shown to repair DNA damage that contributes to Alzheimer’s disease will be launched this week, in a move scientists hope could lead to a cure. The study, being launched in the UK, and hospitals in France and Spain, will, for the first time, see the neuro-degenerative condition treated with an agent which acts as a DNA repair kit to restore memory and reverse behavioural changes such as aggression and social avoidance.
[ad_2]
Read More
